• Organization Name 
    Agios Pharmaceuticals
  • Announced Date Apr 26, 2010
  • Funding Type Series B
  • Funding Stage Early Stage Venture
  • Money Raised 
    $8.8M
  • Celgene Celgene discovers, develops and commercializes innovative therapies to treat cancer and immune-inflammatory-related diseases.
Number of Investors 1
Number of Partner Investors 1
Investor Name  
Partners  
Celgene
Perry Karsen